Nutraferon F-TORSEE 20MG Tablets

By blocking the Na+/K+/2Cl− salt pump in the loop of Henle within the kidneys, Torsemide promotes the excretion of excess sodium and water into the urine. This mobilizes trapped tissue fluid (edema) and reduces intravascular volume and blood pressure.

Torsemide has a reliable 80–90% oral absorption even when the gut wall is swollen from heart or kidney failure, lasts longer from a single morning dose, and is cleared 80% by the liver so its half-life does not prolong dangerously in kidney failure.

Standard Nutraferon F-TORSEE 20 mg is an immediate-release tablet whose diuretic effect begins within 1 hour, peaks at 1 to 2 hours, and lasts 6 to 8 hours. (The original document erroneously referred to it as a controlled-release tablet.)

Never discontinue Torsemide without consulting your prescribing physician, as abrupt cessation in chronic heart failure, CKD, or hypertension can lead to rapid fluid re-accumulation or blood pressure elevation.

Your doctor will monitor serum potassium, sodium, magnesium, creatinine, uric acid (risk of hyperuricemia/gout), and blood glucose. Inform your doctor if you take Lithium (loop diuretics reduce lithium clearance and cause lithium toxicity), Digoxin (hypokalemia increases digoxin arrhythmia risk), NSAIDs (blunt diuretic efficacy and increase AKI risk), or Aminoglycoside antibiotics (additive ototoxicity/hearing risk).